Spinal cord astrocytoma: Response to PCV chemotherapy
Authors:
- 25 January 2000
- journal article
- case report
- Published by Wolters Kluwer Health in Neurology
- Vol. 54 (2) , 518
Abstract
Article abstract Information regarding the value of chemotherapy for spinal cord astrocytomas that progress after irradiation is limited. We describe a patient whose conus medullaris astrocytoma responded to PCV (procarbazine, lomustine, and vincristine) chemotherapy after failing radiation and cisplatin-based chemotherapy. PCV should be considered in patients with progressive spinal cord astrocytomas.Keywords
This publication has 9 references indexed in Scilit:
- Specific Genetic Predictors of Chemotherapeutic Response and Survival in Patients With Anaplastic OligodendrogliomasJNCI: Journal of the National Cancer Institute, 1998
- Treatment of high-grade spinal cord astrocytoma of childhood with “8-in-1” chemotherapy and radiotherapy: a pilot study of CCG-945Journal of Neurosurgery, 1998
- ANNOUNCEMENTNeurosurgery, 1998
- Chemotherapy for spinal cord astrocytomaMedical and Pediatric Oncology, 1997
- The role of radiotherapy in the management of spinal cord gliomaInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1995
- Postoperative radiotherapy of primary spinal cord tumorsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1989
- Primary spinal cord tumors treated with surgery and postoperative irradiationInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1985
- Long-term results of the surgical treatment of 129 intramedullary spinal gliomasJournal of Neurosurgery, 1981
- Management of intramedullary spinal cord tumors.Radiology, 1980